0001179110-17-004432.txt : 20170310 0001179110-17-004432.hdr.sgml : 20170310 20170310170819 ACCESSION NUMBER: 0001179110-17-004432 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170301 FILED AS OF DATE: 20170310 DATE AS OF CHANGE: 20170310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Michael Robert A. CENTRAL INDEX KEY: 0001699914 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 17683013 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 3 1 edgar.xml FORM 3 - X0206 3 2017-03-01 0 0001551152 AbbVie Inc. ABBV 0001699914 Michael Robert A. 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 VP, Controller Common stock, $0.01 par value 21838 D Option (right to buy) 54.86 2026-02-17 Common stock 10140 D Option (right to buy) 61.36 2018-02-16 2027-02-15 Common stock 11420 D Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 3,380 shares on 2/18/2017, and becomes exercisable as to 3,380 shares on 02/18/2018, and 3,380 shares on 02/18/2019. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 3,807 shares on 02/16/2018, 3,806 shares on 02/16/2019, and 3,807 shares on 02/16/2020. Steven L. Scrogham, attorney-in-fact for Robert A. Michael 2017-03-10